COMPASS THERAPEUTICS, INC. Marketable Securities, Unrealized Gain (Loss)
COMPASS THERAPEUTICS, INC. (CMPX) reported Marketable Securities, Unrealized Gain (Loss) of $531.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was $92.00K.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was $439.00K, a 2095.00% increase year-over-year.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $6.00K, a 99.04% decline year-over-year.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $62.00K.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $70.00K, a 59.54% decline from fiscal 2024.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $173.00K.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was -$339.00K, a 212.25% decline from fiscal 2022.
- COMPASS THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was $302.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 3 month as first filed | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $531.00K 10-Q · filed 2026-08-06 | $537.00K derived: sum of 3 quarters · filed 2026-08-06 | $599.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $439.00K 10-Q · filed 2026-05-05 | $445.00K derived: sum of 2 quarters · filed 2026-05-05 | $507.00K derived: sum of 3 quarters · filed 2026-05-05 | $489.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $68.00K derived: sum of 2 quarters · filed 2026-03-05 | $50.00K derived: sum of 3 quarters · filed 2026-08-06 | $70.00K 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $44.00K derived: sum of 2 quarters · filed 2026-08-06 | $64.00K 10-Q · filed 2025-11-05 | $686.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.00K 10-Q · filed 2026-08-06 | -$2.00K 10-Q · filed 2025-08-11 | $624.00K derived: sum of 3 quarters · filed 2026-08-06 | $303.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-05 | -$20.00K 10-Q · filed 2025-05-08 | $642.00K derived: sum of 2 quarters · filed 2026-05-05 | $321.00K derived: sum of 3 quarters · filed 2026-05-05 | $320.00K derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $622.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $301.00K derived: sum of 2 quarters · filed 2026-03-05 | $300.00K derived: sum of 3 quarters · filed 2026-03-05 | $173.00K 10-K · filed 2026-03-05 | -$173.00K 10-K · filed 2025-02-27 | ||
| 2024-09-30 | -$321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$322.00K derived: sum of 2 quarters · filed 2025-11-05 | -$449.00K 10-Q · filed 2025-11-05 | -$916.00K derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$128.00K 10-Q · filed 2025-08-11 | -$595.00K derived: sum of 3 quarters · filed 2025-08-11 | -$262.00K derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | -$127.00K 10-Q · filed 2025-05-08 | -$594.00K derived: sum of 2 quarters · filed 2025-05-08 | -$261.00K derived: sum of 3 quarters · filed 2025-05-08 | -$622.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$467.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$134.00K derived: sum of 2 quarters · filed 2025-02-27 | -$495.00K derived: sum of 3 quarters · filed 2025-02-27 | -$339.00K 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$28.00K derived: sum of 2 quarters · filed 2024-11-12 | $128.00K 10-Q · filed 2024-11-12 | -$211.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$205.00K 10-Q · filed 2024-08-12 | -$544.00K derived: sum of 3 quarters · filed 2024-08-12 | $609.00K derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $156.00K 10-Q · filed 2024-05-13 | -$156.00K 10-Q · filed 2023-05-04 | -$183.00K derived: sum of 2 quarters · filed 2024-05-13 | $970.00K derived: sum of 3 quarters · filed 2024-05-13 | $458.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | -$339.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $814.00K derived: sum of 2 quarters · filed 2024-03-21 | $302.00K derived: sum of 3 quarters · filed 2024-03-21 | $302.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $641.00K derived: sum of 2 quarters · filed 2023-11-09 | $641.00K 10-Q · filed 2023-11-09 | $641.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$512.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$512.00K 10-Q · filed 2023-08-03 | $512.00K 10-Q · filed 2022-08-01 | -$512.00K derived: sum of 3 quarters · filed 2023-08-03 | -$512.00K derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-05-04 | $0.00 derived: sum of 3 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |||||
| 2021-06-20 | $0.00 10-Q · filed 2022-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |